Genotype-Guided Strategy for P2Y12 Inhibitors in Coronary Artery Disease: A Meta-Analysis of Randomized Clinical Trials

Dual-antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone therapy for patients with acute coronary syndrome (ACS) and those undergoing percutaneous coronary intervention (PCI). Despite its widespread use, clopidogrel is hindered by inadequate response in up to 30% of white